Intervention Review

Opioid antagonists for smoking cessation

  1. Sean P. David1,*,
  2. Tim Lancaster2,
  3. Lindsay F Stead2,
  4. A. Eden Evins3,
  5. Kate Cahill2

Editorial Group: Cochrane Tobacco Addiction Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 11 JUN 2009

DOI: 10.1002/14651858.CD003086.pub2

Database Title

Additional Information

How to Cite

David SP, Lancaster T, Stead LF, Evins AE, Cahill K. Opioid antagonists for smoking cessation. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD003086. DOI: 10.1002/14651858.CD003086.pub2.

Author Information

  1. 1

    Stanford University School of Medicine, Department of Medicine (Family & Community Medicine), Stanford, California, USA

  2. 2

    University of Oxford, Department of Primary Health Care, Oxford, UK

  3. 3

    Massachusetts General Hospital, Department of Psychiatry, Boston, Massachusetts, USA

*Sean P. David, Department of Medicine (Family & Community Medicine), Stanford University School of Medicine, Stanford, California, 94305, USA. sean.david@green.oxon.org.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (58K)Standard (307K)Full (323K)

  1. Current Version

    Opioid antagonists for smoking cessation

    Sean P. David, Tim Lancaster, Lindsay F Stead, A. Eden Evins and Kate Cahill

    Article first published online: 7 OCT 2009 | DOI: 10.1002/14651858.CD003086.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Opioid antagonists for smoking cessation

    S David, T Lancaster and LF Stead

    Article first published online: 19 JUL 2006 | DOI: 10.1002/14651858.CD003086

View Full Article (HTML) Summary (58K)Standard (307K)Full (323K)